Mei - Yang

Mei - Yang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2023 in Heliyon
Verified
Journal Article
Open access
DLDan Liang
Dan Liang
CLChang - Liu
Chang - Liu
MYMei - Yang
Mei - Yang
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a serious clinical syndrome with a high morbidity and mortality. Presently, therapeutic approaches for ALI/ARDS primarily revolve around symptomatic supportive care encompassing mechanical ventilation and fluid management. Regrettably, the prognosis for most ALI/ARDS patients remains bleak due to the absence of effective treatment strategies. Even survivors of ALI/ARDS may have long-term pulmonary dysfunction and cognitive impairment. The quality of life has been seriously compromised. The emergence of mesenchymal stem cells (MSCs) and their exosomes has opened up an expansive realm of potential and optimism for addressing the plight of ALI/ARDS patients, as MSCs and their derived exosomes exhibit multifaceted capabilities, including anti-inflammatory properties, facilitation of tissue repair and regeneration, and apoptosis inhibition. Therefore, future research should focus on the possible mechanisms of MSCs and their derived exosomes for the treatment of ALI/ARDS and open up new avenues for their clinical applications.

9 January 2023 in Food & Function
Verified
Journal Article
Closed access
PDF file
LLLingou Li
Lingou Li
HLHanzhang Li
Hanzhang Li
YGYuzhen Gao
Yuzhen Gao
Somayeh VafaeiSomayeh Vafaei
Somayeh Vafaei
XZXingyu Zhang
Xingyu Zhang
MYMei - Yang
Mei - Yang
Many clinical trials have revealed that flaxseed supplementation might exert a potent antihypertensive influence, but the findings are inconsistent. In this regard, a meta-analysis was carried out to provide a more accurate estimate of the impact of flaxseed supplementation on blood pressure. We searched international databases including PubMed, Cochrane Library, Web of Science, Scopus, Embase, and Google Scholar till July 2022. A random-effects model was used to calculate weighted mean differences (WMDs). Non-linear dose–response analysis and meta-regression were performed. Meta-analysis of 33 trials (comprising 43 treatment arms) with 2427 participants revealed significant reductions in both systolic (WMD: −3.19 mmHg; 95% CI: −4.15 to −2.24, p < 0.001; I2 = 92.5%, p < 0.001) and diastolic blood pressure (WMD = −2.61 mmHg; 95% CI: −3.27, −1.94, p < 0.001; I2 = 94.1%, p < 0.001) following flaxseed supplementation. Greater effects on SBP and DBP were found in trials with an intervention duration of >20 weeks, ≥30 g day−1 of flaxseed, subjects with BMI 25–30 kg m−2, and in patients with hypertension. Supplementation with various flaxseed products significantly reduced SBP and DBP levels, confirming the hypothesis that flaxseed could be used as an effective supplement for blood pressure management, alongside routine medications.

11 March 2024 in Analytical Methods
Verified
Journal Article
Closed access
PDF file
XZXingyu Zhang
Xingyu Zhang
JLJie Li
Jie Li
MYMei - Yang
Mei - Yang
HHHong Huang
Hong Huang
HWHao Wang
Hao Wang
HZHongmin Zhang
Hongmin Zhang
Accurate and sensitive low-density lipoprotein (LDL) detection.

19 July 2023 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
PDF file
DLDan Liang
Dan Liang
CLChang - Liu
Chang - Liu
MYMei - Yang
Mei - Yang